
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
The Long Run with Luke Timmerman
Is Small Molecule a Better Modality Than a Biologic?
Ess: Small molecule has certain advantages, like the lower cost of goods. One of the biggest is patient compliance. Biologics have revolutionized health care. They validate the target thit's a great opportunity.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.